**Molecular Mechanism and Rationale**
TREM2 (Triggering Receptor Expressed on Myeloid cells 2) functions as a critical immunoreceptor that orchestrates microglial activation and phagocytic capacity in the central nervous system. The receptor consists of an extracellular immunoglobulin-like domain that recognizes damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs), including phospholipids, lipoproteins, and amyloid-β oligomers. Upon ligand binding, TRE
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.50
Evidence
0.27
Novelty
0.00
Feasibility
0.00
Impact
0.00
Druggability
0.00
Safety
0.00
Competition
0.00
Data
0.50
Reproducible
0.60
KG Connect
0.50
Score Breakdown
Dimension
Test: TREM2 enhances amyloid c
Mechanistic
0.500
Evidence
0.273
Novelty
0.000
Feasibility
0.000
Impact
0.000
Druggability
0.000
Safety
0.000
Competition
0.000
Data
0.500
Reproducible
0.605
KG Connect
0.500
Evidence
Test: TREM2 enhances amyloid clearance
No evidence citations yet
Debate Excerpts
Test: TREM2 enhances amyloid clearance
4 rounds · quality: 0.75
Theorist
# Critical Evaluation: TREM2 Microglial Activation Rescues Amyloid Clearance in Alzheimer's Disease
---
## Mechanistic Rationale
The hypothesis rests on a coherent, genetically informed mechanism...
Skeptic
# Critical Evaluation: TREM2 Microglial Activation Rescues Amyloid Clearance in Alzheimer's Disease
## Building on Round 1 Analysis
The Round 1 critique correctly identified the genetic foundation...
Domain Expert
# Expert Assessment: TREM2 Agonism for Alzheimer's Disease
## Executive Summary
The TREM2 hypothesis remains one of the most genetically validated targets in Alzheimer's disease drug development, ...